Clinical assessments include the Rai3 or Binet4 scores, where adverse outcomes are associated with increasing tumor load and evidence of marrow failure, and the CLL international prognostic index (CLL-IPI)5 which utilizes a combination of clinical and biological characteristics to assess prognosis6–9. The gene discussed is GPRC5A; the disease is B-cell chronic lymphocytic leukemia.